Repeated administration of 2-hydroxypropyl-β-cyclodextrin (HPβCD) attenuates the chronic inflammatory response to experimental stroke

Becktel D.A, Zbesko J.C, Frye J.B, et al. "Repeated administration of 2-hydroxypropyl-β-cyclodextrin (HPβCD) attenuates the chronic inflammatory response to experimental stroke." Journal of Neuroscience. 2022;Jan 42; 2: 325-348.